Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Klingebiel, Thomas  [Clear All Filters]
Journal Article
Jarisch A, Rettinger E, Sörensen J, Klingebiel T, Schäfer R, Seifried E, Bader P, Bonig H. Unstimulated apheresis for chimeric antigen receptor manufacturing in pediatric/adolescent acute lymphoblastic leukemia patients. J Clin Apher. 2020.
Buus-Gehrig C, Bochennek K, Hennies MT, Klingebiel T, Groll AH, Lehrnbecher T. Systemic viral infection in children receiving chemotherapy for acute leukemia. Pediatr Blood Cancer. 2020:e28673.
Bienemann K, Daschkey S, Sörensen J, Schwabe D, Klingebiel T, Hönscheid A, Gombert M, Ginzel S, Borkhardt A. A novel homozygous mutation in UNC13D presenting as Epstein-Barr-virus-associated lymphoproliferative disease at 9 years of age. Leuk Lymphoma. 2016:1-3.
Doberschuetz N, Soerensen J, Bonig H, Willasch A, Rettinger E, Pfirrmann V, Salzmann-Manrique E, Schäfer R, Klingebiel T, Bader P, et al. Mobilized peripheral blood stem cell apheresis via Hickman catheter in pediatric patients. Transfusion. 2019.
Tramsen L, Schmidt S, Roeger F, Schubert R, Salzmann-Manrique E, Latgé J-P, Klingebiel T, Lehrnbecher T. Human Anti-Aspergillus TH1 cells: Immunosuppressive Compounds Exhibit Particular Effects on Functional Properties. Infect Immun. 2014.
Whelan J, Le Deley M-C, Dirksen U, Le Teuff G, Brennan B, Gaspar N, Hawkins DS, Amler S, Bauer S, Bielack S, et al. High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008. J Clin Oncol. 2018:JCO2018782516.
Bremm M, Krastel T, Cappel C, Zimmermann O, Pfeffermann L-M, Katzki V, Bonig H, Schäfer R, Rettinger E, Merker M, et al. Depletion of CD45RA T cells: Advantages and disadvantages of different purification methods. J Immunol Methods. 2021:112960.
Cappel C, Huenecke S, Suemmerer A, Erben S, Rettinger E, Pfirrmann V, Heinze A, Zimmermann O, Klingebiel T, Ullrich E, et al. Cytotoxic potential of IL-15-activated cytokine-induced killer cells against human neuroblastoma cells. Pediatr Blood Cancer. 2016.
Pfirrmann V, Oelsner S, Rettinger E, Huenecke S, Bonig H, Merker M, Wels WS, Cinatl J, Schubert R, Klingebiel T, et al. Cytomegalovirus-specific cytokine-induced killer cells: concurrent targeting of leukemia and cytomegalovirus. Cytotherapy. 2015.
Merker M, Salzmann-Manrique E, Katzki V, Huenecke S, Bremm M, Bakhtiar S, Willasch A, Jarisch A, Soerensen J, Schulz A, et al. Clearance of hematological malignancies by allogeneic cytokine-induced killer cell or donor lymphocyte infusions. Biol Blood Marrow Transplant. 2019.
Thiel U, Wawer A, von Luettichau I, Bender H-U, Blaeschke F, Grunewald TGP, Steinborn M, Röper B, Bonig H, Klingebiel T, et al. Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow. Oncotarget. 2016.